SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Meta forced to unmask anonymous Facebook users in defamation lawsuit

Exit dreams and corporate reality: Untold challenges of Israeli tech acquisitions

What went wrong at AnyVision? Lessons from a $352M flameout

2025 is bringing “a search for meaning” among Israelis, inspiring entrepreneurial dreams

Buzz

Most popular

Daily

Weekly

1

Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M

2

"Wiz is the world's fastest-growing cyber company and together we can build the largest security company to come out of Israel"

3

Warburg Pincus Signs Deal to Acquire Israeli Credit Card Issuer for $680 Million

4

"Everyone will be a manager" - what the world of work will look like with AI agents

5

Survey finds 50% of high-tech startups in Israel may exhaust funds in six months

New Phase

2 stories about New Phase

Groundbreaking Israeli cancer treatment gets FDA approval for clinical trials in U.S.

09.06.24|Ariela Karmel

New Phase CEO Ofer Shalev spoke to CTech about their technology which turns advanced cancer into a chronic ailment, extending the lifespans and treating symptoms without any of the side effects associated with other existing treatments

וידאו Ctech Mind the tech NY conference – Ofer Shalev

“We change cancer from a fatal disease to a chronic ailment”

Ofer Shalev, Founder & CEO at New Phase, spoke to CTech during Mind the Tech NY about New Phase and the technology behind the company